Document is current
Any future updates will be listed below
-
Authors
Jörger, Philippa
Nigg, Carina
Schreck, Leonie
Schindera, Christina
Fessler, Katharina
Waespe, Nicolas
Tomášiková, Zuzana
Ansari, Marc
Frahsa, Annika
Kuehni, Claudia E.
-
Funding
Funding for this research was provided by:
Swiss Cancer Research Foundation (HSR-4951-11-2019)
Krebsliga Schweiz (KLS/KFS-5711-01-2022)
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 31 March 2026
First Online: 11 April 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ethics Committee of the Canton of Bern, Switzerland, KEK-BE 2021 − 01624) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent to participate was obtained from all individual participants included in the study.
: Not applicable.
: Authors PJ, CN, LS, KF, ZT, AF and CK have no relevant financial or nonfinancial interests to disclose. NW reports a relationship with Swedish Orphan Biovitrum AB that includes advisory board membership, consulting, and travel reimbursement and a relationship with Novartis that includes advisory board membership. CS reports a relationship to Swedish Orphan Biovitrum AB that includes travel reimbursement. MA reports a relationship with Jazz Pharmaceutical and Novo Nordisk that includes travel reimbursement. None of these relationships has any association with the current study.
